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Colorectal Cancer Screening With Sigmoidoscopy: Primary Care Issues
Abstract
Colorectal cancer is the second leading cause of death from cancer in the U.S., behind lung cancer. Numerous
medical societies recommend routine screening for colorectal cancer with flexible sigmoidoscopy for people
50 and over. But who will perform the procedure, and who will pay for it? The case of flexible sigmoidoscopy
illustrates the economic and practical issues of introducing a screening procedure into primary care practice.
This Issue Brief investigates the role of primary care physicians in providing this service as part of routine care,
and identifies attitudinal and financial barriers to overcome.
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Colorectal Cancer Screening with Sigmoidoscopy:
Primary Care Issues
Editor’s note: Colorectal cancer is the second leading cause of death from cancer
in the U.S., behind lung cancer. Numerous medical societies recommend routine
screening for colorectal cancer with flexible sigmoidoscopy for people 50 and
over.  But who will perform the procedure, and who will pay for it? The case of
flexible sigmoidoscopy illustrates the economic and practical issues of introduc-
ing a screening procedure into primary care practice. This Issue Brief investigates
the role of primary care physicians in providing this service as part of routine
care, and identifies attitudinal and financial barriers to overcome.
The National Cancer Institute estimates that more than 65,000 people will die
this year of colorectal cancer in the U.S.  Screening can be effective in reducing
mortality because colorectal cancer exists in a readily detectable, easily curable
state for a long time.  Flexible sigmoidoscopy (FS) can detect polyps before they
become cancerous.
• FS examines the inner lining of the rectum and the last two feet of the colon,
where the majority of cancers and polyps develop.  An endoscope—a thin,
flexible tube with a light on the end, is used to identify any polyps or cancer.
Small polyps should be biopsied to determine which patients need further
work-up with colonoscopy.
• Gastroenterologists are trained to perform FS.  However, current estimates
suggest that there are too few gastroenterologists to provide all of the recom-
mended screening sigmoidoscopies.  With training, primary care physicians
(internists and family physicians) could fill the gap.
• A major financial barrier to widespread adoption of FS was seemingly lowered
when Medicare began to cover screening FS for beneficiaries 50 and over as of
January 1998.  Medicare now covers one screening FS every four years for
these beneficiaries, with payment based on the reimbursement rate for diag-
nostic FS.
Previous studies suggest that only 23-67% of primary care physicians routinely
perform FS as part of their practice.  Barriers include:
• Inadequate training.  As with other procedures, supervised training is essential






physicians do not perform
FS in their practice
• Financial factors.  Many physicians believe that insurance reimbursement for
screening FS does not cover the physician’s cost.
• Logistical problems.  Inadequately trained staff and difficult-to-clean equip-
ment may make it inefficient to perform FS in busy office practices.
• Liability concerns.  Physicians may pay higher liability insurance premiums
for performing FS in their practice.
Lewis and Asch estimated the cost, from an individual primary care physician’s
perspective, of performing FS and compared that to the new Medicare reim-
bursement rate. They included fixed and variable costs from estimates in the
published literature.
• Fixed costs included equipment, training, cleaning solution, and additional
malpractice coverage.  These costs were spaced evenly across the life expect-
ancy of the equipment, and training costs were spread over total years of
practice.
• Variable costs included time and additional material required for each proce-
dure.  Time included the time needed to obtain informed consent, perform
the procedure, complete the report, inform the patients of the results, and
arrange any necessary follow-up. Time was measured as the opportunity cost
of performing FS instead of other outpatient clinical activities.  The investiga-
tors assumed that physicians would work the same number of hours, but
reduce the number of patients seen during routine office hours.
Although the financial effect of performing FS is not the only factor affecting
whether a physician performs FS, the level of reimbursement is likely to influ-
ence the decision. Using conservative estimates from the literature, Lewis and
Asch calculated that Medicare reimbursement for FS is barely adequate and, in
some cases, less than the physician’s cost of performing FS in office practice.
• The physician’s total cost for FS without biopsy is $86.86, which is similar to
the Medicare reimbursement rate of $87.84.
• The calculations are most sensitive to estimates of equipment costs, number of
procedures performed each year, and additional malpractice coverage. The
authors estimate that physicians must perform at least 75 procedures per year,
spending 20 minutes or less per procedure, for Medicare reimbursement to
exceed costs.
• The estimated cost for the procedure in a screening program that includes the
ability to perform biopsy is $152.93, which exceeds the Medicare reimburse-
ment rate of $114.77.
In another study, Lewis, Asch and colleagues surveyed physicians to identify the
financial and non-financial factors that influence the decision to perform FS.
They surveyed primary care physicians in community-based practices owned by
the University of Pennsylvania.
Study examines the cost of
performing FS
Medicare reimbursement
for FS is barely adequate





• There was widespread agreement among the physicians about the value of
screening FS.   More than three quarters thought that screening with FS
should be included in routine health care; more than 70% believed that
screening FS reduces mortality from colorectal cancer.
 • 52% of physicians reported training in FS; of those, 53% were currently
performing FS in their practice.  These physicians reported performing a
median of 30 procedures in the preceding year.
• Among physicians trained in FS but not performing the procedure, the most
influential factors were the time required to perform FS, the availability of FS
from other clinicians, and the availability of adequately trained support staff.
Physicians without training in FS and reporting no interest in training also
emphasized the importance of the time required for FS.
• Surprisingly, most physicians did not cite insurance reimbursement rates as a
barrier to performing FS.  This finding may reflect either the small proportion
of these physicians’ total salary that is determined by productivity, or a lack of
knowledge about the effect of performing FS on total revenue.
Previous studies found that physicians choosing to perform FS were more likely
to be men.  The new study found this as well, and isolated some of the reasons
for this gender difference.
• Male and female physicians were equally likely to report having been trained
to perform FS, but male physicians were far more likely to perform FS in
practice after training.  Similarly, male physicians were more likely to report
either currently performing FS or being interested in training to perform FS
(53% vs. 29%).
• These gender differences were largely attributable to the differences in the way
male and female physicians make their decisions.  Specifically, women put
different emphases on the following decision criteria: a sense of duty about
performing FS; the availability of other clinicians to perform FS, the availabil-
ity of equipment, and liability concerns.
• The reasons for these differences are not clear.  Female physicians might be
more likely to have child care responsibilities and other activities that limit
their professional time; these responsibilities may limit their desire to take on
more work, especially if it is time-consuming.
These findings suggest steps that can be taken to increase the likelihood that
primary care physicians will perform FS in office practice.
• Low reimbursement may limit the use of screening FS in primary care prac-
tices.  Medicare rates barely cover the physicians’ cost of providing FS, and do
not cover the costs of providing FS with a biopsy.  Because screening programs
utilizing FS can reduce mortality from colorectal cancer, low reimbursement
rates for the procedure do society a disservice. Medicare reimbursement
should be increased to provide reasonable financial margins within which
primary care physicians can perform FS and operate their practices efficiently.
Male physicians were more
likely than female
physicians to report either
performing FS or wanting
training in FS
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• Physician in community practice voice concern over the time required to
perform FS, and the lack of adequately trained support staff.  Physicians
perceive that the inefficiency of performing office-based FS is a major barrier
to incorporating FS within routine practice. Thus, future efforts should be
directed toward improving the availability of trained support personnel to
assist primary care physicians in performing FS.
• Health systems should consider alternative approaches to delivering colorectal
cancer screening, including having equipment and staff shared by multiple
office locations, or using other health care professionals (such as nurse-
practitioners) to perform FS.
Issue Brief
Published by the
Leonard Davis Institute
of Health Economics
University of Pennsylvania
3641 Locust Walk
Philadelphia, PA 19104-6218
215.898.5611
fax 215.898.0229
ADDRESS CORRECTION REQUESTED
